Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.20932 | 8 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.19371 | 8 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.18619 | 8 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.15236 | 8 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.12723 | 7 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.23632 | 8 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.19543 | 8 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.16219 | 8 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.15751 | 8 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.17209 | 8 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.16781 | 8 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.15524 | 8 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.17619 | 8 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.17417 | 8 |